Tarabeih N, Kalinkovich A, Shalata A, Higla O, Livshits G. Pro-Inflammatory Biomarkers Combined with Body Composition Display a Strong Association with Knee Osteoarthritis in a Community-Based Study. Biomolecules. 2023;13: pubmed publisher

Baccouche B, Lietuvninkas L, Kazlauskas A. Activin A Limits VEGF-Induced Permeability via VE-PTP. Int J Mol Sci. 2023;24: pubmed publisher

Hamalian S, Güth R, Runa F, Sanchez F, Vickers E, Agajanian M, et al. A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers. Oncogene. 2021;40:5224-5235 pubmed publisher

Veraar C, Kliman J, Benazzo A, Oberndorfer F, Laggner M, Hacker P, et al. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction. Sci Rep. 2021;11:6799 pubmed publisher

Pihlstrøm H, Ueland T, Michelsen A, Aukrust P, Gatti F, Hammarstrom C, et al. Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients. PLoS ONE. 2020;15:e0243759 pubmed publisher

Radujkovic A, Boch T, Nolte F, Nowak D, Kunz C, Gieffers A, et al. Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile. Cancers (Basel). 2020;12: pubmed publisher

Janik S, Bekos C, Hacker P, Raunegger T, Schiefer A, Müllauer L, et al. Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors. Sci Rep. 2019;9:17359 pubmed publisher

Roudebush C, Cátala Valentin A, Andl T, Le Bras G, Andl C. Activin A-mediated epithelial de-differentiation contributes to injury repair in an in vitro gastrointestinal reflux model. Cytokine. 2019;123:154782 pubmed publisher

Kress S, Baur J, Otto C, Burkard N, Braspenning J, Walles H, et al. Evaluation of a Miniaturized Biologically Vascularized Scaffold in vitro and in vivo. Sci Rep. 2018;8:4719 pubmed publisher

De Berdt P, Bottemanne P, Bianco J, Alhouayek M, Diogenes A, Lloyd A, et al. Stem cells from human apical papilla decrease neuro-inflammation and stimulate oligodendrocyte progenitor differentiation via activin-A secretion. Cell Mol Life Sci. 2018;75:2843-2856 pubmed publisher

Papaporfyriou A, Bakakos P, Kostikas K, Papatheodorou G, Hillas G, Trigidou R, et al. Activin A and follistatin in patients with asthma. Does severity make the difference?. Respirology. 2017;22:473-479 pubmed publisher

Seeger P, Bosisio D, Parolini S, Badolato R, Gismondi A, Santoni A, et al. Activin A as a mediator of NK-dendritic cell functional interactions. J Immunol. 2014;192:1241-8 pubmed publisher

Weigert J, Neumeier M, Wanninger J, Schober F, Sporrer D, Weber M, et al. Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes. Cytokine. 2009;45:86-91 pubmed publisher

Dower K, Ellis D, Saraf K, Jelinsky S, Lin L. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol. 2008;180:3520-34 pubmed

Alexander S, Watt F, Sawaji Y, Hermansson M, Saklatvala J. Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB. Arthritis Rheum. 2007;56:3715-25 pubmed

Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden A, et al. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 2007;21:2949-60 pubmed